I Capasso
Overview
Explore the profile of I Capasso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capasso I, Liguori B, Verdolotti L, Caputo D, Lavorgna M, Tervoort E
Sci Rep
. 2020 Jan;
10(1):612.
PMID: 31953456
Motivated by the hierarchical micro and nanoscale features in terms of porosity of diatomite, the production of ceramic-graded porous foams with tailored porosity, obtained by using it as raw material,...
2.
Lirer S, Liguori B, Capasso I, Flora A, Caputo D
J Environ Manage
. 2017 Jan;
191:1-7.
PMID: 28082249
Dredging activity in harbours and channels produces huge quantities of sediments, generally considered as waste soil (WS) to be disposed: the management of such sediments is a great environmental problem...
3.
Crispo A, Montella M, Buono G, Grimaldi M, DAiuto M, Capasso I, et al.
Curr Res Transl Med
. 2016 May;
64(1):15-20.
PMID: 27140595
Breast cancer (BC) is the most common malignant tumor in women, obesity is associated with increased BC incidence and mortality and high levels of circulating insulin may negatively impact on...
4.
Esposito E, Anninga B, Harris S, Capasso I, DAiuto M, Rinaldo M, et al.
Br J Surg
. 2015 Mar;
102(6):599-610.
PMID: 25787293
Background: Intraoperative radiotherapy (IORT) constitutes a paradigm shift from the conventional 3-5 weeks of whole-breast external beam radiotherapy (EBRT). IORT enables delivery of radiation at the time of excision of...
5.
Montella M, Biondi E, DeMarco M, Cerra M, Cecco L, Botti G, et al.
Int J Oncol
. 2011 May;
9(5):977-82.
PMID: 21541604
Data from 2933 consecutive cases of primary breast carcinoma, observed in our Institute from 1984 to 1994, having documented estrogen (ER) and progesterone (PR) receptor levels, were obtained from the...
6.
Frasci G, DAiuto G, Comella P, DAiuto M, Di Bonito M, Ruffolo P, et al.
Ann Oncol
. 2009 Oct;
21(4):707-716.
PMID: 19815652
Background: The present article reports the updated survival outcome of the 200 patients enrolled in the Southern Italy Cooperative Oncology Group 9908 trial, which compared 12 weekly cycles of cisplatin-epirubicin-paclitaxel...
7.
Frasci G, Crispo A, DAiuto G, Barba M, Rinaldo M, De Marco M, et al.
J Chemother
. 2008 May;
20(2):269-77.
PMID: 18467256
The purpose of the current analysis was to evaluate the outcome of patients enrolled at the National Cancer Institute of Naples between 1997 and 2000, who underwent breast-conserving surgery. Between...
8.
Curci A, Capasso I, Romano A, Bruni P, Motti M, Pignata S, et al.
Int J Oncol
. 2002 Apr;
20(5):963-70.
PMID: 11956590
We have analyzed 18 families with high incidence of breast cancer or breast and ovarian cancer for the presence of BRCA1 mutations. We identified 4 mutations in the BRCA1 gene...
9.
Frasci G, DAiuto G, Comella P, Thomas R, Capasso I, Botti G, et al.
Semin Oncol
. 2001 Aug;
28(3 Suppl 10):50-6.
PMID: 11510034
We sought to define the recommended dose of cyclophosphamide (CTX) for subsequent phase II assessment when combined with fixed doses of gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) and...
10.
Frasci G, DAiuto G, Comella P, Thomas R, Capasso I, Di Bonito M, et al.
Breast Cancer Res Treat
. 2000 Oct;
62(2):87-97.
PMID: 11016746
Purpose: It has been shown in vitro that both cisplatin and epirubicin increase the antitumor activity of paclitaxel. Weekly administration could give a substantial improvement in the therapeutic index of...